Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Nitrogen

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Nitrogen 99 L/100 L
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
Rx (prescription)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 1986
Label revision date
May 3, 2010
FDA Insert
Prescribing information, PDF file
Active ingredient
Nitrogen 99 L/100 L
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
Rx (prescription)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 1986
Label revision date
May 3, 2010
Manufacturer
Ivey Industries
NDC root
55065-004
FDA Insert
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Nitrogen Refrigerated Liquid NF is a specialized form of nitrogen that is kept at very low temperatures. It is primarily used in various industrial applications, including the preservation of biological samples and in cryogenic processes. This liquid nitrogen is essential for maintaining extremely cold environments, which can be crucial for scientific research and medical procedures.

By providing a reliable source of cold, Nitrogen Refrigerated Liquid NF helps ensure the integrity and longevity of sensitive materials, making it an important tool in both laboratory and medical settings.

Uses

It seems that there are no specific uses or indications provided for this medication. Additionally, there are no details regarding teratogenic effects (which refer to substances that can cause developmental abnormalities in a fetus) or nonteratogenic effects (which do not affect fetal development). If you have any questions or need further information about this medication, please consult your healthcare provider for guidance.

Dosage and Administration

When using this medication, you will apply it topically, which means you will put it directly on your skin. The active ingredient in this product is nitrogen, and it comes in a strength of 99 liters of nitrogen for every 100 liters of the solution.

The medication is packaged in a large container called a DEWAR, which holds 180 liters. Make sure to follow the instructions provided by your healthcare provider regarding how much to use and how often to apply it for the best results.

What to Avoid

It seems that the information regarding what to avoid while using this medication is not specified in the provided text. Therefore, I recommend consulting your healthcare provider or the medication's official guidelines for detailed information on contraindications, controlled substance classification, risks of abuse or misuse, dependence concerns, and specific instructions on when not to take or use the medication. Your safety and well-being are important, so please ensure you have all the necessary information before proceeding.

Side Effects

It's important to be aware that this drug has not been found safe and effective by the FDA, and its labeling has not received FDA approval. This means that there may be significant concerns regarding its use and potential side effects. Always consult with your healthcare provider for more information and guidance tailored to your health needs.

Warnings and Precautions

This drug has not been approved by the FDA for safety and effectiveness, which means it may not be safe for you to use. It's important to be cautious and informed about any medication you consider taking.

Currently, there are no specific precautions or laboratory tests associated with this drug mentioned in the information provided. If you experience any unusual symptoms or have concerns while using this medication, it’s best to stop taking it and consult your doctor for guidance.

Overdose

If you or someone you know has been exposed to too much nitrogen, it can lead to a serious condition called asphyxiation, which happens when there isn’t enough oxygen in the air. Signs of overexposure may include dizziness, headache, confusion, and even loss of consciousness.

If you suspect an overdose, it’s crucial to act quickly. First, move the affected person to an area with fresh air. Then, seek immediate medical attention to ensure their safety and well-being. Remember, acting fast can make a significant difference.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that this drug has not been evaluated by the FDA (U.S. Food and Drug Administration) for safety and effectiveness during pregnancy. As a result, the FDA has not approved its labeling for use in pregnant individuals.

Given this information, you should consult with your healthcare provider to discuss any potential risks and consider alternative options that are known to be safer during pregnancy. Your health and the health of your baby are paramount, so make sure to have open conversations with your doctor about any medications you may be considering.

Lactation Use

When considering the use of this drug while breastfeeding, it's important to note that the FDA has not approved it as safe and effective. This means that there may be unknown risks associated with its use during breastfeeding, which could potentially affect both your milk production and your nursing infant.

If you are breastfeeding or planning to breastfeed, it's crucial to discuss any medications with your healthcare provider to ensure the safety and well-being of both you and your baby. Always prioritize open communication with your doctor about any concerns you may have regarding medications and breastfeeding.

Pediatric Use

It's important to know that this drug has not been approved by the FDA (Food and Drug Administration) for safety and effectiveness in children. This means that there is no official endorsement confirming that it is safe for use in pediatric patients (children). As a parent or caregiver, you should be cautious and consult with a healthcare professional before considering this medication for your child. Always prioritize their safety and well-being by seeking guidance from a qualified medical expert.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, and your healthcare team is there to support you.

Drug Interactions

It's great to know that there are no reported interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or new medications you may start. Open communication helps prevent any potential issues and supports your overall well-being.

Storage and Handling

To ensure the best performance and safety of your product, store it in a DEWAR container, which is designed to maintain low temperatures. It's important to keep the container refrigerated to preserve the integrity of the contents. When handling the product, please do so with care to avoid any spills, as this can compromise its effectiveness and safety. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What is the drug name of this product?

The drug name is Nitrogen Refrigerated Liquid NF.

What is the route of administration for this drug?

The route of administration is topical.

What is the active ingredient in Nitrogen Refrigerated Liquid NF?

The active ingredient is nitrogen.

What is the strength of Nitrogen Refrigerated Liquid NF?

The strength is 99 L in 100 L.

How is Nitrogen Refrigerated Liquid NF packaged?

It is packaged as 180 L in 1 DEWAR.

Are there any specific indications or usage details for this drug?

No specific indications or usage details are provided.

What are the warnings associated with this drug?

This drug has not been found by the FDA to be safe and effective, and this labeling has not been approved by the FDA.

What should I do in case of an emergency?

No specific emergency instructions are provided for this drug.

How should I store Nitrogen Refrigerated Liquid NF?

Store it in a DEWAR container and keep it refrigerated.

What precautions should I take when handling this drug?

Handle with care to avoid spills.

Packaging Info

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Nitrogen.
Details

FDA Insert (PDF)

This is the full prescribing document for Nitrogen, submitted to the U.S. Food and Drug Administration (FDA). It contains official information for healthcare providers, including how to use the medication, possible side effects, and safety warnings.

View FDA-approved insert (PDF)

Description

Nitrogen Refrigerated Liquid NF is classified under UN 1077. It is a cryogenic liquid used in various applications requiring low temperatures. The product is identified by its specific labeling as Nitrogen Refrigerated Liquid NF, ensuring compliance with safety and handling regulations.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the absence of these effects when evaluating treatment options for their patients.

Dosage and Administration

The active ingredient, nitrogen, is to be administered topically. The formulation strength is 99 liters of nitrogen in 100 liters of the preparation. The product is packaged in a 180-liter container, specifically a DEWAR.

Healthcare professionals should ensure that the application site is clean and dry prior to administration. The topical application should be performed according to the specific clinical guidelines relevant to the condition being treated. It is essential to follow the recommended dosing intervals and to monitor the patient for any adverse reactions following administration.

Contraindications

There are no specified contraindications for the use of this product. Healthcare professionals should exercise clinical judgment when considering its use in patients with potential risk factors or underlying conditions.

Warnings and Precautions

This drug has not been evaluated by the FDA for safety and efficacy, and the labeling associated with this product has not received FDA approval. Healthcare professionals should exercise caution when considering the use of this medication, as its safety profile remains unverified.

Currently, there are no specific general precautions or laboratory tests recommended for monitoring the use of this drug. It is essential for healthcare providers to remain vigilant and to assess the individual needs and conditions of their patients when contemplating treatment options.

In the absence of detailed emergency medical instructions or guidance on discontinuation, healthcare professionals are advised to maintain open communication with patients regarding any adverse effects or concerns that may arise during treatment.

Side Effects

This drug has not been found by the FDA to be safe and effective, and this labeling has not been approved by the FDA. As such, there are no established adverse reactions associated with its use. Patients and healthcare providers should be aware that the lack of FDA approval indicates potential risks and uncertainties regarding the safety and efficacy of this drug. It is essential for patients to consult with their healthcare provider for further information and guidance.

Drug Interactions

No drug interactions have been identified in the available data. Additionally, there are no reported interactions between drugs and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Nitrogen.
Details

Pediatric Use

This drug has not been found by the FDA to be safe and effective for pediatric use, and this labeling has not been approved by the FDA. Therefore, healthcare professionals should exercise caution when considering this medication for pediatric patients.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

This drug has not been found by the FDA to be safe and effective for use during pregnancy, and this labeling has not been approved by the FDA. Therefore, the potential risks to pregnant patients and fetal outcomes remain unclear. Healthcare professionals should exercise caution when considering this drug for women of childbearing potential and discuss the potential risks and benefits with their patients. It is essential to weigh the lack of FDA approval against the individual circumstances of each patient when making treatment decisions during pregnancy.

Lactation

This drug has not been found by the FDA to be safe and effective, and this labeling has not been approved by the FDA. Therefore, the effects of this drug on lactating mothers and breastfed infants are not well established. Healthcare professionals should exercise caution when considering the use of this drug in lactating mothers, as the potential risks to the nursing infant are unknown. It is advisable to weigh the benefits of treatment against the potential risks when making decisions regarding the use of this drug during lactation.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

Overdosage of nitrogen can lead to serious health consequences, primarily asphyxiation, which occurs due to the displacement of oxygen in the air. This condition poses a significant risk, particularly in enclosed or poorly ventilated spaces.

Symptoms associated with nitrogen overexposure may manifest as dizziness, headache, confusion, and in severe cases, loss of consciousness. These symptoms indicate a critical need for prompt intervention.

In the event of nitrogen overdosage, it is imperative to take immediate action. The affected individual should be removed to an area with fresh air to alleviate the risk of further exposure. Following this, it is essential to seek immediate medical attention to ensure appropriate evaluation and management of the situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has indicated that this drug has not been found by the FDA to be safe and effective. Consequently, this labeling has not received approval from the FDA.

Patient Counseling

Healthcare providers should inform patients that this drug has not been evaluated by the FDA for safety and efficacy. It is important to communicate that the labeling associated with this drug has not received FDA approval. Patients should be encouraged to discuss any concerns or questions they may have regarding the use of this medication, including potential risks and benefits, with their healthcare provider.

Storage and Handling

The product is supplied in a DEWAR container and must be stored under refrigerated conditions. It is essential to handle the container with care to prevent spills during use.

Additional Clinical Information

No further data are available.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Ivey Industries. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Nitrogen, retrieved by a validated AI data-extraction workflow.

All FDA-approved dosage forms and strengths are listed in the Packaging & NDC Codes section above. Regulatory status, pharmacologic class (EPC), and mechanism of action (MoA) were cross-checked against the FDA Orange Book () and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.